Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Sold by Natixis Advisors LLC
Natixis Advisors LLC lowered its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,910 shares of the biopharmaceutical company’s stock after selling 1,652 shares during the […]
Natixis Advisors LLC lowered its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,910 shares of the biopharmaceutical company’s stock after selling 1,652 shares during the […]
